Skip to main content
Erschienen in: Journal of Nuclear Cardiology 6/2022

10.11.2021 | Original Article

Comparison of diabetes to other prognostic predictors among patients referred for cardiac stress testing: A contemporary analysis from the REFINE SPECT Registry

verfasst von: Donghee Han, MD, Alan Rozanski, MD, Heidi Gransar, MS, Evangelos Tzolos, MD, Robert J. H. Miller, MD, Tali Sharir, MD, Andrew J. Einstein, MD, PhD, Mathews B. Fish, MD, Terrence D. Ruddy, MD, Philipp A. Kaufmann, MD, Albert J. Sinusas, MD, Edward J. Miller, MD, PhD, Timothy M. Bateman, MD, Sharmila Dorbala, MD, MPH, Marcelo Di Carli, MD, Joanna X. Liang, BA, Lien-Hsin Hu, MD, Damini Dey, PhD, Daniel S. Berman, MD, Piotr J. Slomka, PhD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Diabetes mellitus (DM) is increasingly prevalent among contemporary populations referred for cardiac stress testing, but its potency as a predictor for major adverse cardiovascular events (MACE) vs other clinical variables is not well delineated.

Methods and Results

From 19,658 patients who underwent SPECT-MPI, we identified 3122 patients with DM without known coronary artery disease (CAD) (DM+/CAD−) and 3564 without DM with known CAD (DM−/CAD+). Propensity score matching was used to control for the differences in characteristics between DM+/CAD− and DM−/CAD+ groups. There was comparable MACE in the matched DM+/CAD− and DM−/CAD+ groups (HR 1.15, 95% CI 0.97-1.37). By Chi-square analysis, type of stress (exercise or pharmacologic), total perfusion deficit (TPD), and left ventricular function were the most potent predictors of MACE, followed by CAD and DM status. The combined consideration of mode of stress, TPD, and DM provided synergistic stratification, an 8.87-fold (HR 8.87, 95% CI 7.27-10.82) increase in MACE among pharmacologically stressed patients with DM and TPD > 10% (vs non-ischemic, exercised stressed patients without DM).

Conclusions

Propensity-matched patients with DM and no known CAD have similar MACE risk compared to patients with known CAD and no DM. DM is synergistic with mode of stress testing and TPD in predicting the risk of cardiac stress test patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Rozanski A, Berman D. Optimizing the assessment of patient clinical risk at the time of cardiac stress testing. JACC Cardiovasc Imaging 2020;13:616‐23.CrossRef Rozanski A, Berman D. Optimizing the assessment of patient clinical risk at the time of cardiac stress testing. JACC Cardiovasc Imaging 2020;13:616‐23.CrossRef
2.
Zurück zum Zitat Han D, Rozanski A, Gransar H, Sharir T, Einstein AJ, Fish MB. Myocardial ischemic burden and differences in prognosis among patients with and without diabetes: Results from the multicenter international REFINE SPECT Registry. Diabetes Care 2020;43:453‐9.CrossRef Han D, Rozanski A, Gransar H, Sharir T, Einstein AJ, Fish MB. Myocardial ischemic burden and differences in prognosis among patients with and without diabetes: Results from the multicenter international REFINE SPECT Registry. Diabetes Care 2020;43:453‐9.CrossRef
3.
Zurück zum Zitat Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229‐34.CrossRef Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229‐34.CrossRef
4.
Zurück zum Zitat Schramm TK, Gislason GH, Kober L, Rasmussen S, Rasmussen JN, Abildstrom SZ, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: A population study of 3.3 million people. Circulation 2008;117:1945‐54.CrossRef Schramm TK, Gislason GH, Kober L, Rasmussen S, Rasmussen JN, Abildstrom SZ, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: A population study of 3.3 million people. Circulation 2008;117:1945‐54.CrossRef
5.
Zurück zum Zitat Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med 2009;26:142‐8.CrossRef Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med 2009;26:142‐8.CrossRef
6.
Zurück zum Zitat Rana JS, Liu JY, Moffet HH, Jaffe M, Karter AJ. Diabetes and prior coronary heart disease are not necessarily risk equivalent for future coronary heart disease events. J Gen Intern Med 2016;31:387‐93.CrossRef Rana JS, Liu JY, Moffet HH, Jaffe M, Karter AJ. Diabetes and prior coronary heart disease are not necessarily risk equivalent for future coronary heart disease events. J Gen Intern Med 2016;31:387‐93.CrossRef
7.
Zurück zum Zitat Morales DCV, Bhavnani SP, Ahlberg AW, Pullatt RC, Katten DM, Polk DM, et al. Coronary risk equivalence of diabetes assessed by SPECT-MPI. J Nucl Cardiol 2019;26:1093‐102.CrossRef Morales DCV, Bhavnani SP, Ahlberg AW, Pullatt RC, Katten DM, Polk DM, et al. Coronary risk equivalence of diabetes assessed by SPECT-MPI. J Nucl Cardiol 2019;26:1093‐102.CrossRef
8.
Zurück zum Zitat Slomka PJ, Betancur J, Liang JX, Otaki Y, Hu LH, Sharir T, et al. Rationale and design of the REgistry of Fast Myocardial Perfusion Imaging with NExt generation SPECT (REFINE SPECT). J Nucl Cardiol 2018;27:1010.CrossRef Slomka PJ, Betancur J, Liang JX, Otaki Y, Hu LH, Sharir T, et al. Rationale and design of the REgistry of Fast Myocardial Perfusion Imaging with NExt generation SPECT (REFINE SPECT). J Nucl Cardiol 2018;27:1010.CrossRef
9.
Zurück zum Zitat Gambhir SS, Berman DS, Ziffer J, Nagler M, Sandler M, Patton J, et al. A novel high-sensitivity rapid-acquisition single-photon cardiac imaging camera. J Nucl Med 2009;50:635‐43.CrossRef Gambhir SS, Berman DS, Ziffer J, Nagler M, Sandler M, Patton J, et al. A novel high-sensitivity rapid-acquisition single-photon cardiac imaging camera. J Nucl Med 2009;50:635‐43.CrossRef
10.
Zurück zum Zitat Herzog BA, Buechel RR, Katz R, Brueckner M, Husmann L, Burger IA, et al. Nuclear myocardial perfusion imaging with a cadmium-zinc-telluride detector technique: Optimized protocol for scan time reduction. J Nucl Med 2010;51:46‐51.CrossRef Herzog BA, Buechel RR, Katz R, Brueckner M, Husmann L, Burger IA, et al. Nuclear myocardial perfusion imaging with a cadmium-zinc-telluride detector technique: Optimized protocol for scan time reduction. J Nucl Med 2010;51:46‐51.CrossRef
11.
Zurück zum Zitat Dorbala S, Ananthasubramaniam K, Armstrong IS, Chareonthaitawee P, DePuey EG, Einstein AJ, et al. Single Photon Emission Computed Tomography (SPECT) myocardial perfusion imaging guidelines: Instrumentation, acquisition, processing, and interpretation. J Nucl Cardiol 2018;25:1784‐846.CrossRef Dorbala S, Ananthasubramaniam K, Armstrong IS, Chareonthaitawee P, DePuey EG, Einstein AJ, et al. Single Photon Emission Computed Tomography (SPECT) myocardial perfusion imaging guidelines: Instrumentation, acquisition, processing, and interpretation. J Nucl Cardiol 2018;25:1784‐846.CrossRef
12.
Zurück zum Zitat Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900‐7.CrossRef Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900‐7.CrossRef
13.
Zurück zum Zitat Nakazato R, Berman DS, Gransar H, Hyun M, Miranda-Peats R, Kite FC, et al. Prognostic value of quantitative high-speed myocardial perfusion imaging. J Nucl Cardiol 2012;19:1113‐23.CrossRef Nakazato R, Berman DS, Gransar H, Hyun M, Miranda-Peats R, Kite FC, et al. Prognostic value of quantitative high-speed myocardial perfusion imaging. J Nucl Cardiol 2012;19:1113‐23.CrossRef
14.
Zurück zum Zitat Imbens GW. The role of the propensity score in estimating dose-response functions. Biometrika 2000;87:706‐10.CrossRef Imbens GW. The role of the propensity score in estimating dose-response functions. Biometrika 2000;87:706‐10.CrossRef
15.
Zurück zum Zitat Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics 2000;56:645‐6.CrossRef Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics 2000;56:645‐6.CrossRef
16.
Zurück zum Zitat Cameron AC, Miller DL. A practitioner’s guide to cluster-robust inference. J Hum Resour 2015;50:317‐72.CrossRef Cameron AC, Miller DL. A practitioner’s guide to cluster-robust inference. J Hum Resour 2015;50:317‐72.CrossRef
17.
Zurück zum Zitat Control CfD, Prevention. National diabetes statistics report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services 2020. Control CfD, Prevention. National diabetes statistics report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services 2020.
18.
Zurück zum Zitat Rozanski A, Gransar H, Min JK, Hayes SW, Friedman JD, Thomson LE, et al. Long-term mortality following normal exercise myocardial perfusion SPECT according to coronary disease risk factors. J Nucl Cardiol 2014;21:341‐50.CrossRef Rozanski A, Gransar H, Min JK, Hayes SW, Friedman JD, Thomson LE, et al. Long-term mortality following normal exercise myocardial perfusion SPECT according to coronary disease risk factors. J Nucl Cardiol 2014;21:341‐50.CrossRef
19.
Zurück zum Zitat Navare SM, Mather JF, Shaw LJ, Fowler MS, Heller GV. Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: A meta-analysis. J Nucl Cardiol 2004;11:551‐61.CrossRef Navare SM, Mather JF, Shaw LJ, Fowler MS, Heller GV. Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: A meta-analysis. J Nucl Cardiol 2004;11:551‐61.CrossRef
20.
Zurück zum Zitat Supariwala A, Uretsky S, Depuey EG, Thotakura G, Kanneganti S, Guriginjakunta N, et al. Influence of mode of stress and coronary risk factor burden upon long-term mortality following normal stress myocardial perfusion single-photon emission computed tomographic imaging. Am J Cardiol 2013;111:846‐50.CrossRef Supariwala A, Uretsky S, Depuey EG, Thotakura G, Kanneganti S, Guriginjakunta N, et al. Influence of mode of stress and coronary risk factor burden upon long-term mortality following normal stress myocardial perfusion single-photon emission computed tomographic imaging. Am J Cardiol 2013;111:846‐50.CrossRef
21.
Zurück zum Zitat Acampa W, Petretta M, Cuocolo R, Daniele S, Cantoni V, Cuocolo A. Warranty period of normal stress myocardial perfusion imaging in diabetic patients: A propensity score analysis. J Nucl Cardiol 2014;21:50‐6.CrossRef Acampa W, Petretta M, Cuocolo R, Daniele S, Cantoni V, Cuocolo A. Warranty period of normal stress myocardial perfusion imaging in diabetic patients: A propensity score analysis. J Nucl Cardiol 2014;21:50‐6.CrossRef
22.
Zurück zum Zitat Nappi C, Gaudieri V, Acampa W, Assante R, Zampella E, Mainolfi CG, et al. Comparison of left ventricular shape by gated SPECT imaging in diabetic and nondiabetic patients with normal myocardial perfusion: A propensity score analysis. J Nucl Cardiol 2018;25:394‐403.CrossRef Nappi C, Gaudieri V, Acampa W, Assante R, Zampella E, Mainolfi CG, et al. Comparison of left ventricular shape by gated SPECT imaging in diabetic and nondiabetic patients with normal myocardial perfusion: A propensity score analysis. J Nucl Cardiol 2018;25:394‐403.CrossRef
23.
Zurück zum Zitat Assante R, Acampa W, Zampella E, Arumugam P, Nappi C, Gaudieri V, et al. Coronary atherosclerotic burden vs. coronary vascular function in diabetic and nondiabetic patients with normal myocardial perfusion: A propensity score analysis. Eur J Nucl Med Mol Imaging 2017;44:1129‐35.CrossRef Assante R, Acampa W, Zampella E, Arumugam P, Nappi C, Gaudieri V, et al. Coronary atherosclerotic burden vs. coronary vascular function in diabetic and nondiabetic patients with normal myocardial perfusion: A propensity score analysis. Eur J Nucl Med Mol Imaging 2017;44:1129‐35.CrossRef
24.
Zurück zum Zitat Wagenknecht LE, Zaccaro D, Espeland MA, Karter AJ, O’Leary DH, Haffner SM. Diabetes and progression of carotid atherosclerosis: The insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol 2003;23:1035‐41.CrossRef Wagenknecht LE, Zaccaro D, Espeland MA, Karter AJ, O’Leary DH, Haffner SM. Diabetes and progression of carotid atherosclerosis: The insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol 2003;23:1035‐41.CrossRef
25.
Zurück zum Zitat Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: Molecular and pathophysiological mechanisms. Circulation 2006;113:1888‐904.CrossRef Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: Molecular and pathophysiological mechanisms. Circulation 2006;113:1888‐904.CrossRef
26.
Zurück zum Zitat Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: The role of reparatory mechanisms. Diabetes Care 2011;34:S285‐90.CrossRef Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: The role of reparatory mechanisms. Diabetes Care 2011;34:S285‐90.CrossRef
27.
Zurück zum Zitat Kim U, Leipsic JA, Sellers SL, Shao M, Blanke P, Hadamitzky M, et al. Natural history of diabetic coronary atherosclerosis by quantitative measurement of serial coronary computed tomographic angiography: Results of the PARADIGM Study. JACC Cardiovasc Imaging 2018;11:1461‐71.CrossRef Kim U, Leipsic JA, Sellers SL, Shao M, Blanke P, Hadamitzky M, et al. Natural history of diabetic coronary atherosclerosis by quantitative measurement of serial coronary computed tomographic angiography: Results of the PARADIGM Study. JACC Cardiovasc Imaging 2018;11:1461‐71.CrossRef
28.
Zurück zum Zitat Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 2004;43:1663‐9.CrossRef Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 2004;43:1663‐9.CrossRef
29.
Zurück zum Zitat Wong ND, Cordola Hsu AR, Rozanski A, Shaw LJ, Whelton SP, Budoff MJ, et al. Sex differences in coronary artery calcium and mortality from coronary heart disease, cardiovascular disease, and all causes in adults with diabetes: The Coronary Calcium Consortium. Diabetes Care 2020;43:2597‐606.CrossRef Wong ND, Cordola Hsu AR, Rozanski A, Shaw LJ, Whelton SP, Budoff MJ, et al. Sex differences in coronary artery calcium and mortality from coronary heart disease, cardiovascular disease, and all causes in adults with diabetes: The Coronary Calcium Consortium. Diabetes Care 2020;43:2597‐606.CrossRef
30.
Zurück zum Zitat Elkeles RS, Godsland IF, Feher MD, Rubens MB, Roughton M, Nugara F, et al. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: The PREDICT study. Eur Heart J 2008;29:2244‐51.CrossRef Elkeles RS, Godsland IF, Feher MD, Rubens MB, Roughton M, Nugara F, et al. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: The PREDICT study. Eur Heart J 2008;29:2244‐51.CrossRef
31.
Zurück zum Zitat Muhlestein JB, Lappé DL, Lima JA, Rosen BD, May HT, Knight S, et al. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: The FACTOR-64 randomized clinical trial. JAMA 2014;312:2234‐43.CrossRef Muhlestein JB, Lappé DL, Lima JA, Rosen BD, May HT, Knight S, et al. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: The FACTOR-64 randomized clinical trial. JAMA 2014;312:2234‐43.CrossRef
32.
Zurück zum Zitat Blanke P, Naoum C, Ahmadi A, Cheruvu C, Soon J, Arepalli C, et al. Long-term prognostic utility of coronary CT angiography in stable patients with diabetes mellitus. JACC Cardiovasc Imaging 2016;9:1280‐8.CrossRef Blanke P, Naoum C, Ahmadi A, Cheruvu C, Soon J, Arepalli C, et al. Long-term prognostic utility of coronary CT angiography in stable patients with diabetes mellitus. JACC Cardiovasc Imaging 2016;9:1280‐8.CrossRef
33.
Zurück zum Zitat Skali H, Murthy VL, Al-Mallah MH, Bateman TM, Beanlands R, Better N, et al. Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMI. J Nucl Cardiol 2020;27:1022‐9.CrossRef Skali H, Murthy VL, Al-Mallah MH, Bateman TM, Beanlands R, Better N, et al. Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMI. J Nucl Cardiol 2020;27:1022‐9.CrossRef
Metadaten
Titel
Comparison of diabetes to other prognostic predictors among patients referred for cardiac stress testing: A contemporary analysis from the REFINE SPECT Registry
verfasst von
Donghee Han, MD
Alan Rozanski, MD
Heidi Gransar, MS
Evangelos Tzolos, MD
Robert J. H. Miller, MD
Tali Sharir, MD
Andrew J. Einstein, MD, PhD
Mathews B. Fish, MD
Terrence D. Ruddy, MD
Philipp A. Kaufmann, MD
Albert J. Sinusas, MD
Edward J. Miller, MD, PhD
Timothy M. Bateman, MD
Sharmila Dorbala, MD, MPH
Marcelo Di Carli, MD
Joanna X. Liang, BA
Lien-Hsin Hu, MD
Damini Dey, PhD
Daniel S. Berman, MD
Piotr J. Slomka, PhD
Publikationsdatum
10.11.2021
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 6/2022
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-021-02810-8

Weitere Artikel der Ausgabe 6/2022

Journal of Nuclear Cardiology 6/2022 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.